New dopaminergic and potential anti-parkinson compounds, N,N-disubstituted beta-(3,4-dihydroxyphenyl)ethylamines.
D000818:Animals; D000978:Antiparkinson Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D002421:Caudate Nucleus / Q000502:physiology; D004298:Dopamine / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D006801:Humans; D051379:Mice; D051381:Rats; D013239:Stereotyped Behavior; D013329:Structure-Activity Relationship; D013378:Substantia Nigra / Q000502:physiology
D000978:Antiparkinson Agents; D004298:Dopamine